MS Speaks
Multiple Sclerosis => TREATMENTS => LEMTRADA (Campath, alemtuzumab) => Topic started by: agate on July 23, 2018, 07:49:08 pm
-
From Multiple Sclerosis and Related Disorders (July 2018), "Neutropenia with fatal outcome in a multiple sclerosis patient 23 days after alemtuzumab infusion":
https://www.msard-journal.com/article/S2211-0348(18)30133-0/abstract